Impact of DM on Restenosis after DES Implantation
SES showed significant reduction of restenosis, which did not translate into improved clinical outcomes owing to small population Kastrati et al., NEJM 2005; 353:663-70 Nine-month outcomes Lee SW, Park SW, et al. J Am Coll Cardiol 2008; 52:727-33 
SIRTAX Trial SIRTAX Trial

Objective
To compare the effectiveness of sirolimuseluting stent (SES) and paclitaxel-eluting stent (PES) in patients with DM. Lee SW, Park SW, et al. J Am Coll Cardiol 2008; 52:727-33 
DES-DIABETES Trial Design
The lesions Suitable for PCI in patients with DM 
SES (200 patients)
